Annals of Dermatology, 36 (6), 384388
Pharmacological determinants in GLP-1RA-Associated cancer risk Differential cancer risk profiles across GLP-1RA subtypes and dosing regimens Existing studies underscore significant differences in the effect of various GLP-1RAs on the risk of specific cancers, such as pancreatic cancer [6,7,8, 26, 27]
Several states are dropping weight loss coverage of GLP-1s from their version of Medicaid, including California's Medi-cal program
While reduced cravings can be beneficial, the medication is not approved as an alcohol-use treatment and should never be used as a substitute for evidence-based addiction care
Study that gives important insight into the molecular mode of action of GLP-1 by identifying the cellular localization of GLP-1R in monkey and human tissue using the most extensively validated monoclonal antibody to date
But here's what my research uncovered: What They Promise: Significant weight loss without the side effects of prescription medications, using "natural GLP-1 activation." What Users Actually Experience: Out of dozens of user reviews I analyzed, the overwhelming consensus was disappointing
